EPH149 Risk Factors of Delayed Methotrexate Elimination after Receiving High-Dose Methotrexate Therapy

Abstract

Authors

C.A. Liang

Full Text Cite This Article
Back to Volume 26, Supplemental Issue 6S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×